Dr Lalchand. Lab, a company in the Healthcare Service Provider industry, reported revenue of ₹2.13 crore and a net loss of ₹0.13 crore for the March 2026 quarter.
Dr Lalchand. Lab (BSE: DLCL) closed at ₹6.48 on 20 Nov 2026, down 56.7% over the past year. Its market capitalisation is ₹6 crore and it trades at 93.3 times earnings.
Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories for pathological investigations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.